StockData
CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc. (CNSP) stock

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$4.44+0.29 (+6.99%)

Close on Nov 18, 2026Market cap $6.49MP/E –Yield –

CNS Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CNS Pharmaceuticals's market cap was $5.29M on Nov 11, 2026, against $3.99M a year earlier. Over the last 5 years it ranged from $1.44M to $11.57B, with a median of $626.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.29M+75.4%
2025Dec 31, 2025$3.02M-99.9%
2024Dec 31, 2024$2.42B-24.6%
2023Dec 29, 2023$3.21B+66.8%
2022Dec 30, 2022$1.92B-83.4%
2021Dec 31, 2021$11.57B-34.9%
2020Dec 31, 2020$17.79B-44.8%
2019Dec 31, 2019$32.21B–

More CNS Pharmaceuticals figures

See a number that looks wrong?